StemCell Institute Inc. (TYO:7096)

Japan flag Japan · Delayed Price · Currency is JPY
1,281.00
-24.00 (-1.84%)
May 12, 2025, 3:30 PM JST
-32.93%
Market Cap 13.37B
Revenue (ttm) 2.64B
Net Income (ttm) 395.00M
Shares Out 10.25M
EPS (ttm) 38.55
PE Ratio 33.85
Forward PE n/a
Dividend 25.00 (1.92%)
Ex-Dividend Date n/a
Volume 44,000
Average Volume 16,625
Open 1,300.00
Previous Close 1,305.00
Day's Range 1,254.00 - 1,300.00
52-Week Range 1,097.00 - 1,970.00
Beta 0.64
RSI 46.21
Earnings Date May 13, 2025

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 98
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7096
Full Company Profile

Financial Performance

In 2023, StemCell Institute's revenue was 2.48 billion, an increase of 18.65% compared to the previous year's 2.09 billion. Earnings were 310.00 million, an increase of 56.57%.

Financial Statements

News

There is no news available yet.